 |
Transcriptome mapping: ER-binding sites dynamics reveal new strategy for breast cancer biomarkers |
|
|
|
50-52 |
|
|
Genome-based diagnostics and therapeutics in personalized cancer therapy: Can the challenges be overcome? |
|
|
|
53-57 |
|
|
Science and technology: revealing genome networks for improving health |
|
|
|
58-64 |
|
|
‘Sequence everything' strategy in the clinical cancer genome era |
|
|
|
65-71 |
|
|
Tumor heterogeneity-based personalized oncology
|
|
|
|
72-78 |
|
|
Progress in treating laparoscopically advanced gastric cancer |
|
|
|
79-81 |
|
|
Precision medicine: Neoadjuvant treatment and laparoscopic rectal cancer resection |
|
|
|
82-84 |
|
|
Laparoscopic gastrectomy: Challenges and perspectives in predicting morbidity and relapse risk in gastric cancer.
|
|
|
|
85-87 |
|
|
Safety and quality of life improvement expand laparoscopic resection for gastric cancer |
|
|
|
88-90 |
|
|
Pre-treatment diagnostics of esophageal cancer and the role of EUS |
|
|
|
91-93 |
|
|
Management of advanced non-clear cell renal carcinoma. |
|
|
|
94-101 |
|
|
Solid cancer: Evaluating potential efficacy of epigenetic drugs. |
|
|
|
102-107 |
|
